State NC
Clinical Trials in North Carolina
Recruiting clinical trials with at least one study location in North Carolina. Data updated daily from ClinicalTrials.gov.
Top Conditions in North Carolina
NCT02474160 N/A
Recruiting
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
5,000 pts
Location
United States
Sponsor
National Cancer Institute LAO
NCT06122779 Phase 2
Recruiting
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in ...
Condition
Heart Failure
Enrollment
208 pts
Location
United States, Argentina, Canada
Sponsor
Bristol-Myers Squibb
NCT06875973 Phase 3
Recruiting
Pelacarsen Roll-over Extension Program
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
599 pts
Location
United States, Puerto Rico
Sponsor
Novartis Pharmaceuticals
NCT05739123 N/A
Recruiting
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-...
Condition
Pregnancy Related
Enrollment
728 pts
Location
United States
Sponsor
Sumitomo Pharma Switzerland Gm
NCT07216742 Phase 3
Recruiting
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live ...
Condition
Infertility (IVF Patients)
Enrollment
659 pts
Location
United States
Sponsor
Granata Bio Corporation
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT05010603 N/A
Recruiting
Late Onset Alzheimer's Disease
Condition
Alzheimer Disease
Enrollment
10,000 pts
Location
United States
Sponsor
Columbia University
NCT04205968 Phase 2
Recruiting
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Condition
Metastatic Small Intestinal Adenocarcinoma
Enrollment
94 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT05285527 N/A
Recruiting
MiSight 1 Day Safety Post-Approval Study
Condition
Myopia
Enrollment
2,400 pts
Location
United States, Canada
Sponsor
CooperVision, Inc.
NCT02182180 N/A
Recruiting
SC2i Tissue and Data Repository Protocol
Condition
Critical Illness
Enrollment
5,000 pts
Location
United States
Sponsor
Henry M. Jackson Foundation fo
NCT06972446 Phase 2
Recruiting
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Ar...
Condition
Rheumatoid Arthritis
Enrollment
180 pts
Location
United States, Canada, Czechia
Sponsor
AbbVie
NCT05920356 Phase 3
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab P...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT04772131 N/A
Recruiting
Desara ® One Single Incision Sling 522 Study
Condition
Stress Urinary Incontinence
Enrollment
300 pts
Location
United States
Sponsor
Caldera Medical, Inc.
NCT04775745 Phase 1
Recruiting
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B...
Condition
CLL/SLL
Enrollment
60 pts
Location
United States
Sponsor
Newave Pharmaceutical Inc
NCT06568939 Phase 2
Recruiting
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzuma...
Condition
Non-Small Cell Lung Cancer
Enrollment
150 pts
Location
United States, China, Israel
Sponsor
AbbVie
NCT03486873 Phase 3
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tum...
Condition
Solid Tumors
Enrollment
3,500 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06228053 Phase 2
Recruiting
Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castrati...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
53 pts
Location
United States
Sponsor
Syntrix Biosystems, Inc.
NCT05218083 N/A
Recruiting
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program W...
Condition
COVID-19
Enrollment
120 pts
Location
United States
Sponsor
Duke University
NCT06809179 Phase 2
Recruiting
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Do...
Condition
Social Anxiety Disorder
Enrollment
60 pts
Location
United States
Sponsor
VistaGen Therapeutics, Inc.
NCT05946629 N/A
Recruiting
SELUTION 4 De Novo Small Vessel IDE Trial
Condition
Coronary Artery Disease
Enrollment
960 pts
Location
United States
Sponsor
M.A. Med Alliance S.A.
NCT02932618 Phase 3
Recruiting
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Ch...
Condition
Von Willebrand Disease
Enrollment
31 pts
Location
United States, Austria, Belgium
Sponsor
Baxalta now part of Shire
NCT05895045 N/A
Recruiting
Yoga for Treatment of Overactive Bladder in Pediatric Patients
Condition
Overactive Bladder
Enrollment
40 pts
Location
United States
Sponsor
Duke University
NCT07382167 Phase 3
Recruiting
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopa...
Condition
Chronic Idiopathic Constipation (CIC)
Enrollment
692 pts
Location
United States
Sponsor
Ardelyx
NCT06958536 Phase 2
Recruiting
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's...
Condition
Crohn's Disease
Enrollment
99 pts
Location
United States, Australia, Belgium
Sponsor
Sanofi
NCT05257551 N/A
Recruiting
Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study
Condition
Small Cell Lung Cancer
Enrollment
50 pts
Location
United States
Sponsor
Tempus AI